Sars-cov-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational coco immune study

HIGHLIGHTS

• who: Alexandra Jablonka-Dopfer from the Department of General Practice, University Medical Center Gu00f6ttingen, Humboldtallee, Gu00f6ttingen, Germany have published the research work: SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study, in the Journal: (JOURNAL)
• what: The aims of the COVID-19 Contact (CoCo) Immune Study are therefore to determine both, (a) if a COVID-19 vaccination provokes humoral immunity to the SARS-CoV-2 spike glycoprotein, defined as neutralizing antibody responses to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.